Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome

Clinical Neurophysiology

Volumn 119, Issue 11, 2008, Pages 2455-2458

  Buoni, Sabrina ^a   Zannolli, Raffaella ^a   Felice, Claudio De ^a   Saponari, Simona ^b   Strambi, Mirella ^a   Dotti, Maria Teresa ^b   Castrucci, Elena ^b   Corbini, Letizia ^a   Orsi, Alessandra ^a   Hayek, Joseph ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Drug resistant epilepsy; EEG pattern; MECP2 gene; Rett syndrome

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; ADULT; ARTICLE; CHI SQUARE TEST; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; FOLLOW UP; GENE DELETION; GENE DUPLICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RETT SYNDROME; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHYL-CPG-BINDING PROTEIN 2; MUTATION; PHENOTYPE; RETROSPECTIVE STUDIES; RETT SYNDROME; YOUNG ADULT;

EID: 54349096983     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2008.08.015     Document Type: Article

References (14)

1. Berg A.T., and Kelly M.M. Defining intractability: comparisons among published definitions. Epilepsia 47 (2006) 431-436
2. French J.A. Refractory epilepsy: clinical overview. Epilepsia 48 Suppl 1 (2007) 3-7
3. Glaze D.G., Frost Jr. J.D., Zoghbi H.Y., and Percy A.K. Rett's syndrome: correlation of electroencephalographyc characteristic with clinical staging. Arch Neurol 44 (1987) 1053-1056
4. Glaze D.G. Neurophysiology of Rett syndrome. Ment Retard Dev Disabil Rev 8 (2002) 66-71
5. Hagberg B, Hanefeld F, Percy A, Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome: comments to Rett syndrome clinical criteria consensus panel satellite to European paediatric neurology society meeting, Baden Baden, Germany, September 11, 2001. Eur J Paediatr Neurol 2002;6:293-97.
6. Hagberg B., and Witt-Engerstrom I. Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet 26 (1986) 47-59
7. Hagberg B. Clinical manifestation of stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 8 (2002) 61-65
8. Kumar A., Kamboj S., Malone B.M., Kudo S., Twiss J.L., Czymmek K.J., et al. Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J Cell Sci 121 (2008) 1128-1137
9. Jian L., Nagarajan L., de Klerk N., Ravine D., Bower C., Anderson A., et al. Predictors of seizure onset in Rett syndrome. J Pediatr 149 (2006) 542-547
10. Moser S.J., Weber P., and Lutschg J. Rett syndrome: clinical and electrophysiologic aspects. Pediatr Neurol 36 (2007) 95-100
11. Percy A., and Lane J. Rett syndrome: clinical and molecular update. Curr Opin Pediatr 16 (2004) 670-677
12. Sander J.W. The epidemiology of epilepsy revisited. Curr Opin Neurol 16 (2003) 165-170
13. Steffenburg U., Hagberg G., and Hagberg B. Epilepsy in a representative series of Rett syndrome. Acta Paediatr 90 (2001) 34-39
14. Witt-Engerstrom I. Age related occurrence of signs and symptoms in the Rett syndrome. Brain Dev 14 suppl (1992) S11-20